share_log

5 Cheapest Health Care Stocks You Should Think About

5 Cheapest Health Care Stocks You Should Think About

您應該考慮的 5 種最便宜的醫療保健股
Benzinga Real-time News ·  2023/01/27 08:51

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

醫療保健行業最賣的股票提供了購買價值低估公司的機會。

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.

RSI 是一個動量指標，它比較股票在價格下跌的日子裡價格上升到其強勢的日子裡的實力。與股票的價格走勢相比，它可以使交易者更好地了解股票在短期內的表現。當 RSI 低於 30 時，資產通常被認為是超賣。

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

這是該行業中主要超賣參與者的最新列表，RSI 接近或低於 30。

Third Harmonic Bio, Inc. (NASDAQ:THRD)

第三諧波生物有限公司 (納斯達克:第三)

  • Third Harmonic Bio, last month, announced discontinuation of its Phase 1b study of THB001 in chronic inducible urticaria.. The company's stock has a 52-week low of $3.89 .
  • RSI Value: 28.67
  • THRD Price Action: Shares of Third Harmonic Bio settled at $4.25 on Thursday and added 6.4% in after-hours trading.
  • 第三諧波生物, 上個月, 宣布停止其在慢性誘導性蕁麻疹 THB001 的 1b 階段研究。.該公司的股票有 五十二周低點為 3.89 美元 。
  • RSI 值: 28.67
  • 價格行動: 第三諧波生物股份於星期四收市後交易時段為 4.25 美元，收市後交易時段增加 6.4%。

Bio-Techne Corporation (NASDAQ:TECH)

生技股份有限公司 (納斯達克:技術)

  • Wells Fargo recently upgraded the stock from Underweight to Equal-Weight. The company's stock has a 52-week low of $68.00.
  • RSI Value: 29.19
  • TECH Price Action: Shares of Bio-Techne rose 0.6% to close at $80.32 on Thursday.
  • 富國銀行最近將股票從體重過輕升級到同等重量。該公司的 股票有 52 周低點 的 68.00 美元。
  • RSI 值: 29.19
  • 科技價格行動： 生物科技股價上漲 0.6%，收於 80.32 美元。

AbbVie Inc. (NYSE:ABBV)

艾伯维公司 (紐約證交所:ABBV)

  • Piper Sandler recently maintained AbbVie with an Overweight and raised the price target from $155 to $157.. The company's stock has a 52-week low of $133.05.
  • RSI Value: 28.94
  • ABBV Price Action: Shares of AbbVie fell 0.3% to close at $147.40 on Thursday and added 0.2% in after-hours trading.
  • 派珀桑德勒最近維持了超重的 AbVie，並將目標價格從 155 美元提高到 157 美元。該公司的股票有 52 週 零五年三月的低點。
  • RSI 值: 28.94
  • ABBV 價格行動： 艾伯維的股票在周四下跌 0.3%，收盤收於 147.40 美元，收市後交易時段增加 0.2%。

1Life Healthcare, Inc. (NASDAQ:ONEM)

1 生命醫療股份有限公司 (納斯達克:奧奈姆)

  • 1Life Healthcare, during November, posted a Q3 loss of $0.57 per share. The company's 52-week low is $5.94.
  • RSI Value: 29.09
  • ONEM Price Action: Shares of 1Life Healthcare fell 0.7% to close at 15.98 on Thursday and lost 0.8% in after-hours trading.
  • 1 生命醫療, 在十一月期間, 發布了 Q3 損失 每股 0.57 美元。該公司的 52 周低點是 5.94 美元。
  • RSI 值: 29.09
  • 歐奈姆價格行動： 一生醫療股份下跌 0.7% 至周四 15.98 收盤，收市後交易時段下跌 0.8%。

Fate Therapeutics, Inc. (NASDAQ:FATE)

命運治療, 公司. （納斯達克：命運）

  • HC Wainwright & Co. downgraded Fate Therapeutics from Buy to Neutral and lowered the price target from $115 to $7. The company has a 52-week low of $4.02.
  • RSI Value: 24.79
  • FATE Price Action: Shares of Fate Therapeutics fell 1.9% to close at $5.30 on Thursday and lost 1.3% in after-hours trading.
  • 韋賴特公司將命運治療從「買入」降級為中性，並將目標價格從 115 美元降至 7 美元。該公司 有 52 週的低點 的 4.02 美元。
  • RSI 值: 24.79
  • 命運價格行動： 命運治療學的股價在周四下跌 1.9%，收於 5.30 美元，收盤後交易時段下跌 1.3%。

Read More: Investor Optimism Improves Further Following GDP Report

閱讀更多： GDP 報告後投資者樂觀情緒進一步改善

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論